ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

TORONTO, Jan. 31, 2019 /CNW/ – ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled customer base. This past year, ACTO secured global, innovative pharmaceutical, medical device, and dental companies like Kala Pharmaceuticals, Teleflex, and Kulzer Dental US as clients. “At ACTO, we are on a …

Terms of use

ACTO Terms and Conditions Terms and Conditions. These Terms and Conditions (“ACTO Terms and Conditions”) govern the Customer’s subscription to certain of ACTO’s platform and products and engagement of ACTO to perform certain related services, each as more particularly described in the relevant Order Form and Statement of Work (“SOW”) and attached hereto and incorporated by reference herein (the “Platform,” …

ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group

Toronto, October 26, 2022: ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence (AI) by Everest Group, a leading global research firm focused exclusively on strategic IT, business process, and engineering services. In its  “Start-ups Creating Buzz in the Life Sciences Commercial Technology” 2022 market report,  Everest Group …

Episode 7: How is Technology Reshaping the Medical Device Industry?

Featuring: Liv Williamsen is a medical device industry leader with nearly 20 years of experience, and has worked with a wide range of medical device companies from a Fortune 50 company to small start-ups. She has been responsible for building new markets in and outside of the US, leading sales & marketing teams, developing and running training programs for sales …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …

ACTO and Teleflex Collaboration Leads to Improved Sales Performance and Wins Bronze in the 2019 Brandon Hall Group Human Capital Management Excellence Awards for Learning Technology Implementation

TORONTO, Sept. 17, 2019 /CNW/ – ACTO and Teleflex’s Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the “Best Advance in Learning Technology Implementation” category for their groundbreaking efforts to improve sales performance. The ACTO and Teleflex case study demonstrates the commercial success that life sciences companies can achieve after implementing new technology to gather field data and …

ACTO Wins Gold Stevie® Award in the Cloud Platform Category in 2019 International Business Awards

TORONTO, Aug. 22, 2019 /CNW/ – ACTO was named the winner of a Gold Stevie® Award in the Cloud Platform category in The 16th Annual International Business Awards®. The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. The 2019 IBAs received …

ACTO and Philips Respironics Partnership Earns Nomination for the 2019 LTEN Excellence Award in Innovation

TORONTO, June 3, 2019 /CNW/ – ACTO and Philips Respironics’ partnership has earned a nomination for the 2019 LTEN Excellence Award in Innovation, honoring best-in-class learning and development initiatives within the life sciences. LTEN has recognized ACTO for their work with Philips Respironics in implementing the ACTO Commercialization Cloud. “In the past, training was a check-the-box event,” said Parth Khanna, CEO of ACTO, …

ACTO Named One of the 2019 PM360 ELITE 100

TORONTO, May 21, 2019 /CNW/ – PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Parth Khanna, Kapil Kalra, and Kumar Erramilli as one of the 2019 PM360 ELITE 100 in the Entrepreneurs category. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. …